Sesen Bio, Inc. announced an increase of the one-time special cash dividend expected to be paid to stockholders to $75.0 million, or approximately $0.36 per share. This represents an increase from the expected special cash dividend of approximately $70.0 million, or approximately $0.34 per share1, under the first amendment to the merger agreement, and an increase from the up to $25.0 million special cash dividend under the terms of the original merger agreement dated September 20, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.445 USD | +1.76% | +2.86% | -50.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.85% | 58.99M | |
+9.37% | 114B | |
+13.61% | 107B | |
-9.50% | 22.22B | |
-1.60% | 21.28B | |
-4.55% | 18.8B | |
-5.62% | 17.51B | |
-39.93% | 17.17B | |
+7.00% | 14.14B | |
+34.62% | 12.2B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Sesen Bio, Inc. Announces Increase of One-Time Special Cash Dividend